Inspire Investing LLC lifted its stake in shares of Ventas, Inc. (NYSE:VTR - Free Report) by 24.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 97,457 shares of the real estate investment trust's stock after purchasing an additional 19,008 shares during the quarter. Inspire Investing LLC's holdings in Ventas were worth $8,286,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Dynamic Wealth Strategies LLC acquired a new position in Ventas in the first quarter valued at about $25,000. Silvant Capital Management LLC acquired a new stake in Ventas during the second quarter worth about $28,000. Meeder Asset Management Inc. acquired a new stake in Ventas during the second quarter worth about $30,000. Western Wealth Management LLC acquired a new stake in Ventas during the first quarter worth about $40,000. Finally, Ascentis Independent Advisors acquired a new stake in Ventas during the first quarter worth about $44,000. 94.18% of the stock is owned by institutional investors and hedge funds.
Ventas Price Performance
Shares of VTR opened at $86.86 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a market cap of $44.55 billion, a PE ratio of 160.85, a PEG ratio of 3.40 and a beta of 0.72. Ventas, Inc. has a 12-month low of $68.15 and a 12-month high of $101.60. The business has a 50-day simple moving average of $87.89 and a two-hundred day simple moving average of $88.06.
Ventas (NYSE:VTR - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%. The business's revenue for the quarter was up 21.7% on a year-over-year basis. During the same period last year, the firm posted $0.87 earnings per share. Analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.
Ventas Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were given a dividend of $0.52 per share. The ex-dividend date was Wednesday, September 30th. This represents a $2.08 annualized dividend and a yield of 2.4%. Ventas's dividend payout ratio (DPR) is currently 385.19%.
Wall Street Analyst Weigh In
Several brokerages have recently commented on VTR. BNP Paribas Exane boosted their target price on shares of Ventas from $93.00 to $110.00 and gave the company an "outperform" rating in a research report on Thursday, July 30th. Citigroup raised their price target on shares of Ventas from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Tuesday, August 4th. Wells Fargo & Company decreased their price target on shares of Ventas from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday. JPMorgan Chase & Co. upped their price objective on shares of Ventas from $94.00 to $104.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 2nd. Finally, Mizuho increased their price objective on shares of Ventas from $98.00 to $104.00 and gave the company an "outperform" rating in a research note on Wednesday, July 22nd. Eighteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Ventas has an average rating of "Moderate Buy" and a consensus price target of $98.91.
Check Out Our Latest Report on Ventas
Ventas Company Profile
(
Free Report)
Ventas, Inc NYSE: VTR is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.
Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.